CoChat

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

Gene therapy for hemophilia

Open access
Nathwani, Amit C. · 2019 · Hematology

Abstract

Gene therapy offers the potential for a cure for patients with hemophilia by establishing continuous endogenous expression of factor VIII or factor IX (FIX) following transfer of a functional gene to replace the hemophilic patient’s own defective gene. The hemophilias are ideally suited for gene therapy because a small increment in blood factor levels (≥5% of normal) is associated with significant amelioration of bleeding phenotype in severely affected patients. In 2011, the St. Jude/UCL phase 1/2 trial was the first to provide clear evidence of a stable dose-dependent increase in FIX levels in patients with severe hemophilia B following a single administration of adeno-associated viral (AAV) vectors. Transgenic FIX expression has remained stable at ∼5% of normal in the high-dose cohort over a 7-year follow-up period, resulting in a substantial reduction in spontaneous bleeding and FIX protein usage without toxicity. This study has been followed by unparalleled advances in gene therapy for hemophilia A and B, leading to clotting factor activity approaching normal or near-normal levels associated with a “zero bleed rates” in previously severely affected patients following a single administration of AAV vectors. Thus, AAV gene therapies are likely to alter the treatment paradigm for hemophilia A and B. This review explores recent progress and the remaining limitations that need to be overcome for wider availability of this novel treatment of inherited bleeding disorders.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/hematology.2019000007

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 47 references

Research works printed but not linked: 3

  1. Roth, 2002, Implantation of non-viral ex vivo genetically modified autologous dermal fibroblasts that express B-domain deleted human factor VIII in 12 severe hemophilia A study subjects, Blood, 100, 116a
  2. George, 2018, SPK-8011: Preliminary results from a phase 1/2 trial of investigational gene therapy for hemophilia A, Haemophilia, 24, 30
  3. Konkle, 2019, Initial results of the Alta study, a phase 1/2, open label, adaptive, dose-ranging study to assess the safety and tolerability of SB-525 gene therapy in adult subjects with severe hemophilia A

Cited by

See all 140

Metadata

Authors
Nathwani, A. C.
Affiliations
Royal Free London NHS Foundation Trust (GB)
Corresponding author
Nathwani, Amit C.
Venue
Hematology
Published
2019-12-06
Volume
2019
Issue
1
Pages
1-8
ISSN
  • 1520-4383 (ISSN-L)
  • 1520-4391
OpenAlex
W2994542907
Cited by
140
References
47
Citations by year
2026: 8 · 2025: 11 · 2024: 21 · 2023: 22 · 2022: 31 · 2021: 29 · 2020: 17 · 2019: 1
FWCI
3.10
Type
journal article
Language
en
Open access
Locations
  • Hematology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institute for Health and Care Research (NF-SI-0513-10071)
  • Rosetrees Trust
  • Medical Research Council (MR/L013185/1)
Topics
  • Health Sciences › Medicine › Hematology › Hemophilia Treatment and Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
Keywords
gene therapy, hemophilia, hemophilia A, hemophilia B, adeno-associated virus vectors, factor VIII, factor IX, bleeding phenotype, inherited bleeding disorders
MeSH terms
Animals, Clinical Trials as Topic, Genetic Vectors, Hemophilia A, Humans, Genetic Therapy, Gene Transfer Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Gene therapy for hemophilia. https://app.cochat.ai/papers/10.1182/hematology.2019000007
The paper
Nathwani, A. C. (2019). Gene therapy for hemophilia. Hematology. https://doi.org/10.1182/hematology.2019000007

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.